Literature DB >> 2198848

Two enteric coated microspheres in cystic fibrosis.

J Williams1, A MacDonald, P H Weller, J Fields, H Pandov.   

Abstract

In a randomised single blind crossover study in children with cystic fibrosis and pancreatic insufficiency, two enteric coated microsphere preparations of pancreatin were compared on a capsule for capsule basis, by measuring the coefficient of fat absorption, nitrogen excretion, weight change, and symptom scores after four weeks' treatment with each preparation. Thirty nine subjects were randomly allocated to receive Pancrease followed by Creon or vice versa. Each individual subject received the same number of capsules per day in each study period. Data from 27 children (Pancrease/Creon, n = 13 and Creon/Pancrease, n = 14) wer suitable for analysis. Results showed no significant differences between the two preparations in any variable studied. We conclude that there is no significant difference between Pancrease and Creon when compared on a capsule for capsule basis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198848      PMCID: PMC1792062          DOI: 10.1136/adc.65.6.594

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

Authors:  E P DiMagno; J R Malagelada; V L Go; C G Moertel
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

2.  Recent observations on pathogenesis of cystic fibrosis of the pancreas.

Authors:  P A DI SANT'AGNESE
Journal:  Pediatrics       Date:  1959-08       Impact factor: 7.124

3.  Human postprandial gastric emptying of 1-3-millimeter spheres.

Authors:  J H Meyer; J Elashoff; V Porter-Fink; J Dressman; G L Amidon
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

4.  Faecal chymotrypsin: a reliable index of exocrine pancreatic function.

Authors:  G A Brown; D Sule; J Williams; J W Puntis; I W Booth; A S McNeish
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

5.  Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.

Authors:  A Lapey; J Kattwinkel; P A Di Sant'Agnese; L Laster
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

6.  An enteric-coated pancreatic enzyme preparation that works.

Authors:  D Y Graham
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

7.  Comparison of four pancreatic extracts in cystic fibrosis.

Authors:  D W Beverley; J Kelleher; A MacDonald; J M Littlewood; T Robinson; M P Walters
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

8.  Does mixing pancreatic enzyme microspheres (Pancrease) with food damage the enteric coating?

Authors:  J W Sackman; K E Smith; D Y Graham
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

9.  Weight-for-height indices to assess nutritional status--a new index on a slide-rule.

Authors:  T J Cole; M L Donnet; J P Stanfield
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

10.  Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.

Authors:  E H Mischler; S Parrell; P M Farrell; G B Odell
Journal:  Am J Dis Child       Date:  1982-12
View more
  5 in total

Review 1.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

2.  Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.

Authors:  M J Bruno; J J Borm; F J Hoek; B Delzenne; A F Hofmann; J J de Goeij; E A van Royen; D J van Leeuwen; G N Tytgat
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

Review 3.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

Review 4.  Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.

Authors:  Christabella Ng; Giles Major; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2021-08-02

5.  Pancreatic enzyme replacement therapy for people with cystic fibrosis.

Authors:  Usha Rani R Somaraju; Arturo Solis-Moya
Journal:  Cochrane Database Syst Rev       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.